OPtical frequency domain imaging vs. INtravascular ultrasound in percutaneous coronary InterventiON in patients with Acute Coronary Syndrome: Study protocol for a randomized controlled trial
OPtical frequency domain imaging vs. INtravascular ultrasound in percutaneous coronary InterventiON in patients with Acute Coronary Syndrome: Study protocol for a randomized controlled trial
复制标题
光学频域成像与血管内超声在急性冠状动脉综合征患者经皮冠状动脉介入治疗中的比较:随机对照试验的研究方案
DOI:
10.1016/j.jjcc.2020.03.010
复制
发表时间:
2020
影响因子:
2.5
通讯作者:
Akasaka Takashi
中科院分区:
文献类型:
--
作者:
Otake Hiromasa;Kubo Takashi;Shinke Toshiro;Hibi Kiyoshi;Tanaka Shigemitsu;Ishida Masaru;Kataoka Toru;Takaya Tomofumi;Iwasaki Masamichi;Sonoda Shinjo;Ioji Tetsuya;Akasaka Takashi
BackgroundA recent clinical trial demonstrated that optical frequency domain imaging (OFDI) guidance in percutaneous coronary intervention (PCI) is noninferior to intravascular ultrasound (IVUS) guidance in patients with coronary artery disease with regard to target vessel failure (composed of cardiac death, myocardial infarction attributed to the target vessel, and clinically-driven target vessel revascularization) at 12 months. The impact of OFDI guidance in PCI for patients with acute coronary syndrome (ACS) remains uncertain.MethodsOPINION ACS is a multicenter, prospective, randomized, controlled, open-label, parallel group, non-inferiority trial in Japan. Eligible patients will be randomly assigned to receive either OFDI- or IVUS-guided PCI. PCI is performed using the sirolimus-eluting stent in accordance with certain OFDI and IVUS criteria for optimal stent deployment. All patients will undergo follow-up angiography and OFDI imaging at 8 months. The primary endpoint is the minimum lumen area, as measured by OFDI at 8 months.ConclusionThe OPINION ACS trial outcomes will provide insights regarding the impact of OFDI-guided PCI on in-stent restenosis at 8 months in patients with ACS.